Israel Englander’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Israel Englander’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-22,500	Closed	-$8K	–	4039
2016 Q3	$8K	Buy	+22,500	New	+$8K	﹤0.01%	3226
2015 Q2	–	Sell	-73,164	Closed	-$102K	–	4246
2015 Q1	$102K	Sell	73,164 -166,480	-69%	-$232K	﹤0.01%	3403
2014 Q4	$362K	Buy	239,644 +215,444	+890%	+$325K	﹤0.01%	3223
2014 Q3	$50K	Sell	24,200 -8,206	-25%	-$17K	﹤0.01%	3599
2014 Q2	$99K	Sell	32,406 -7,901	-20%	-$24.1K	﹤0.01%	3253
2014 Q1	$101K	Buy	+40,307	New	+$101K	﹤0.01%	3300
2013 Q4	–	Sell	-35,422	Closed	-$81K	–	4146
2013 Q3	$81K	Buy	35,422 +17,076	+93%	+$39K	﹤0.01%	3198
2013 Q2	$41K	Buy	+18,346	New	+$41K	﹤0.01%	2919

Israel Englander's RXII Position: Q4 2016 in Review

Israel Englander sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 22,500 shares — an estimated $8K sold.

Israel Englander first reported a position in RXII in Q2 2013 and held it in 8 quarters. The position peaked at $362K in Q4 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Israel Englander reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Israel Englander sold 22,500 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $8K.
Israel Englander first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 8 quarters.
Israel Englander's GALENA BIOPHARMA INC COM position peaked at $362K in Q4 2014.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.